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Rhomboid peptidases are conserved intramembrane serine proteases with
mitochondrial family members being involved in mitochondrial dynamics and apoptosis.
The Saccharomyces cerevisiae mitochondrial rhomboid, Pcp1p, catalyzes the cleavage of
two substrates: Ccp1p, which breaks down reactive oxygen species, and Mgm1p, a
GTPase mediating mitochondrial fusion events. As an initial approach to determine the
structural basis of Pcp1p activity, a screen to identify temperature sensitive alleles of
PCP1 was performed using hydroxylamine mutagenesis. Eight mutants were identified
from a pool of 30,000 colonies that exhibited either temperature sensitive growth or
respiratory defects. These mutants also exhibited defects in Mgm1p and Ccp1p
processing and some degree of abnormal mitochondrial morphology. The majority of
amino acid changes occurred within the fourth and sixth transmembrane domains of
Pcp1p, the location of the active site serine and histidine residues, supporting a role for
these transmembrane helices in Pcp1p activity.
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CHAPTER I
INTRODUCTION

Mitochondrial structure and morphology
The mitochondrion is a double membraned organelle found in most eukaryotic
cells and is well known as the central source of energy production. The mitochondrion
was first recognized as the ‘bioblast’ by Altmann in 1890 [4], however the organelle
ultrastructure, and the fact that it contained its own DNA (mtDNA), was not determined
until the 1960s. The discovery of mtDNA gave support to the endosymbiotic theory,
which asserts that mitochondria developed from proteobacteria, originally acquired by an
ancestral eukaryote by endosymbiosis [50].
There are four distinct compartments within mitochondria, from outside to inside:
the outer membrane, the intermembrane space (space between the outer and inner
membranes), the inner membrane, and the matrix (space within the inner membrane).
The outer membrane (OM) encloses the entire organelle and is a relatively simple
phospholipid bilayer containing integral proteins called porins which are permeable to
molecules less than 5 kilo Daltons in size such as ions, carbohydrates, and ATP/ADP.
Larger molecules are transported across the outer membrane by specific transport proteins, generally referred to as translocases. The inner membrane (IM) has a similar
thickness as the OM, but a higher mass ratio of protein to phospholipid and includes the
1

complexes of the electron transport chain, the ATP synthetase complex, and transporters
of small molecules and proteins. The inner membrane is only freely permeable to oxygen
and carbon dioxide, all other materials (amino acids, ATP/GTP, pyruvic acid, iron,
mitochondrial proteins, etc.) must be transported by specific carrier proteins. The
invaginations of the inner membrane form the cristae which greatly increase the total
surface area of the inner membrane providing space for more of the above named
structures to function properly and efficiently. The region between the outer and inner
membrane is the intermembrane space and is where oxidative phosphorylation takes
place. The matrix contains the mitochondrial genome (mtDNA), tRNA, ribosomes, and
enzymes of the citric acid cycle.

Figure 1.1

Mitochondrial structural features.

Cristae are formed by invaginations of the inner membrane and contain enzymes of the
electron transport chain, increasing the surface area for ATP synthesis and other
activities.
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Mitochondria are not static, they continuously changing their shape, forming a
dynamic tubular network within the cell. In cultured animal cells, mitochondria are
localized along microtubules, while in budding yeast and plant cells mitochondria
movement is along the actin cytoskeleton [51]. The morphology and density of
mitochondria vary for different cell types and cell stages. For example, mitochondrial
morphology changes dramatically during yeast meiosis, with mitochondria fusing to form
long branched structure in zygotes and dividing into spherical mitochondria in spores [1].
In synapses, mitochondrial density increases rapidly after neuronal stimulation [10],
while a higher number of mitochondria are found in liver cells, muscle cells, and neurons
compared to adipocytes and epidermal cells.
Role of morphology in cell function
In addition to its primary function of supplying cellular energy (ATP) through
oxidative phosphorylation [4], mitochondria are also involved in regulating cellular
metabolism, apoptosis, cell stress response, aging, branched chain amino and heme
synthesis, and Fe-S cluster assembly. Mitochondrial morphology has a significant impact
on all of these processes [17].
In yeast, defects in the tubular mitochondrial network often leads to loss of the
mitochondrial genome (mtDNA) resulting in respiratory deficiency. Cells which display
such a condition are unable to utilize nonfermentable carbon for growth, exhibit slow
growth on fermentable carbon, and are referred to as petites.
In humans, abnormal mitochondrial morphology results, directly or indirectly, in
diverse diseases. Dominant optic atrophy (DOA) is the most common inherited disease of
3

the optic nerve, with the incidence rate of 0.02-0.83‰ [11]. Individuals with this disease
have visual problems with blindness resulting at an early age. This disease has been
linked to mutations in OPA1, a dynamin-related protein implicated in mitochondrial
fusion events. In cultured HeLa cells, the inhibition of OPA1 expression by siRNA
triggers apoptosis, this may explain the abnormal apoptosis of retinal ganglion cells in
DOA patients [13]. Charcot-Marie-Tooth neuropathy (CMT) is a (0.4‰, [52]) inherited
peripheral neuropathy, which arises from mutations in the mitochondrial fusion protein
MFN2 [48]. To date, 25 different mutations have been identified in MFN2 among CMT
patients. Silencing mfn2 in mouse embryonic fibroblasts and HeLa cells results in an
increased distance between mitochondria and ER, thus reducing the Ca2+ uptake of
mitochondria [14], thereby increasing free Ca2+ concentration mediated apoptosis.
Therefore, mitochondrial dynamics have been shown to influence programmed cell death
[15]. In addition to the examples provided above, inhibition of Drp1 (Dynamic related
protein), the mediator of mitochondrial fission, blocks OM scission and mediates cell
death [18]. Mitochondrial dynamics also play a role in neurodegenerative diseases such
as Alzheimer’s and Parkinson’s. The mtDNA deficient human neuroblastoma cells from
Alzheimer’s and Parkinson’s patients exhibited more enlarged mitochondria with fewer
cristae than mitochondria in neuroblastoma cells from age-matched controls [8].
Proteins involved in mitochondrial fusion – fission events in eukaryotes
Changes in mitochondrial morphology are due to two opposing processes, fusion
and fission [20]. Fusion is a GTP and inner membrane potential dependent activity that
works to join adjacent mitochondria. Fission is also a GTP dependent event and is what
4

promotes mitochondrial division. Both events are driven by protein complexes found in
the OM and IMS.
The fusion pathway is controlled by several GTPases that govern the activity of
membrane remodeling, and include Fzo1p (Fuzzy onion), Mgm1p (mitochondrial
genome maintenance), and Ugo1p (Japanese for fusion).
Fzo1p was the first identified protein mediator of mitochondrial fusion. Male fruit
flies harboring the fzo1 mutation are defective in mitochondrial fusion during
spermatogenesis and are sterile [21]. A similar defect in mitochondrial fusion is seen in

Δfzo1 yeast mutants [23]. Fzo1p is a multispanning transmembrane protein embedded in
the OM through two hydrophobic domains (Figure 1.2), with three coiled-coil domains
and a GTPase domain in N-terminus and one coiled-coil domain in C-terminus exposed
to cytoplasm. The human homolog of FZO1 is MFN1/2, or mitofusin. Mfn1 and Mfn2
are 81% similar to each other and both proteins have a role in mitochondrial fusion. They
form either homotypic or heterotypic trans complexes between adjacent mitochondria,
and only homotypic complexes are functional for mediating membrane apposition.
Murine Mfn1 and Mfn2 are both 52% similar to Drosophila Fzo1p with transmembrane
domain, GTPase domain and coiled-coil domain [53]. In embryonic fibroblast cells,
Mfn1 and Mfn2 deletion resulted in severe fragmented mitochondria. Either Δmfn1 or

Δmfn2 retained a low level of fusion activity, with approximately 4.5% of mutant cells
containing significant tubules [25].
In yeast, Mgm1p is another important GTPase involved in mitochondrial fusion.
Cells deleted for mgm1 have no mitochondrial fusion activity. Instead of forming a
5

tubular network, mitochondria are fragmented and spherical [28]. Mgm1p also plays a
role in cristae formation and maintenance [6]. In addition to one GTPase domain and one
central domain, Mgm1p contains a mitochondrial targeting sequence (MTS) at the Nterminus followed by a matrix processing peptidase (MPP) cleavage site, a hydrophobic
transmembrane domain (TM), and lastly a second transmembrane segment that contains a
Pcp1p cleavage site. There are two isoforms of Mgm1p in mitochondria, a long isoform
and a short isoform. Cleavage of the Mgm1p precursor by MPP generates the long
isoform of Mgm1p of 100kD, while further processing by Pcp1p produces the short form
of 90kD. The long isoform is integrated in the IM, while the short isoform is soluble in
the IMS [1, 2, 9]. Both isoforms and their relative ratio are essential for the proper
activity of Mgm1p. Overexpression of the long isoform has a negative effect on
mitochondrial fusion, while the GTPase activity mediates the fusion of the inner
membrane and is only required in the short isoform [5]. The human ortholog of MGM1
is OPA1 (optic atrophy), the gene identified in patients with DOA. There has been
conflicting reports detailing OPA1 function. For example, cells lacking OPA1 have
disorganized cristae and defects in fusion [29, 30], while overexpression of OPA1 results
in fragmented mitochondria [32]. One possible explanation for the conflict: like Mgm1p,
Opa1p is dually processed although processing to the second isoform is limited. So over
expression of OPA1 may affect the ratio of the two isoforms which may explain why
both over expression and deletion of OPA1 have negative impact on mitochondrial
fusion.
The third GTPase, Ugo1p, is found only in fungi and localizes to the OM with its
C-terminal region located in the cytosol and its N-terminus in the IMS. Ugo1p, Fzolp and
6

Mgm1p work as a complex to carry out the mitochondrial fusion process. Fzo1p controls
OM fusion, while Mgm1p is required for both OM and IM fusion [33]. The cytoplasmic
domain of Ugo1p interacts with Fzo1p while its intermembrane space domain associates
with Mgm1p [34]. This interaction is essential for mitochondrial fusion.

Figure 1.2

Diagram of the fusion protein complex in mitochondria [34].

Fzo1p localizes to the OM with its GTPase domain and carboxy-terminus positioned in
the cytoplasm. The long isoform of Mgm1p is embedded in the IM with its N-terminus
in the matrix. After cleavage by Pcp1p, the short isoform is released as a soluble protein
in the IMS. Ugo1p may interact with both Fzo1p and Mgm1p and assist them with fusion
activities.
The mitochondrial fission process in yeast is mediated primarily through the
activity of three proteins: Dnm1p, Mdv1p, and Fis1p.
Dnm1p (dynamin) is a GTPase localized to the cytoplasmic face of mitochondria
[35], where it plays an essential role in mitochondrial fission. The homolog of Dnm1p in
human is Drp1p (dynamin- related protein). The N-terminus of Dnm1p contains the
GTPase domain, which is followed by a central hydrophilic region, and a C-terminal
GED (GTPase effector domain). The GED domain mediates Dnm1p self-assembly in the
7

early stages of mitochondrial fission. The fragmented mitochondrial phenotype of fzo1
mutants can be rescued by DNM1 deletion, indicating that the activity of Dnm1p results
in mitochondrial fission in fzo1 mutants [17]. Mdv1p (mitochondrial division) is a soluble
protein that associates with Dnm1p in fission-mediated punctuate structures evenly
distributed on the cytoplasmic side of the OM [36].
Mdv1p contains an N-terminal extension (NTE) domain and seven WD40 (40
amino acids with conserved Tyr and Asp) repeats at its C-terminus that forms a βpropeller. Fis1p (fission) is an integral OM protein whose carboxy-terminus is embedded
in the OM, while its N-terminus forms a six α-helical structure that functions as a
receptor exposed to the cytoplasm [37].
In a presumed fission model, Dnm1p self-assembles on the mitochondrial surface,
forming a ring shaped complex around a mitochondrial tubule. Mdv1p and Fis1p form a
stable complex by interacting with the NTE and six α-helices. The WD40 domain of
Mdv1p contributed to the corporation of the two complexes, triggering late events of
membrane division (Figure 1.3, 17).
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Figure 1.3

Diagram of the fission protein complex in mitochondria.

For Mdv1p, the yellow star represents the WD40 domain. The NTE region of Mdv1p
interacts with six α-helices of Fis1p.
The balance between mitochondrial fusion and fission is regulated by Mdm30p
(mitochondrial distribution and morphology) and the mitochondrial rhomboid protease,
Pcp1p. Mdm30p contains an F-box motif, which forms the SCF (Skp1p, Cdc53p and Fbox) complex, an E3 ubiquitin ligase, which together with ubiquitin enzymes (E1, E2)
catalyzes the ubiquitylation of proteins, targeting them for degradation. Fzo1p levels
increase when MGM30 is deleted and decreases with the over expression of Mdm30p,
suggesting that Fzo1p is a substrate for Mdm30p mediated degradation [38, 39, 40]. How
Mgm30p regulates mitochondrial morphology remains to be elucidated.
Rhomboid proteases
Rhomboid proteases are highly conserved serine peptidases that cleave substrates
within the hydrophobic membrane [7]. Rhomboid proteases were first identified in a
systematic screen in Drosophila. The absence of this gene resulted in abnormal
rhomboid- shaped head skeleton, hence the name [41]. Later research showed this
rhomboid (Rhd1p) cleaves the membrane-anchored growth factor Spitz, to activate the
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epidermal growth factor receptor (EGFR) signaling pathway [42]. Since then, the
rhomboid protease family has been widely studied. There are two subfamilies, the RHO
subfamily, which participate in cell signaling pathways found in non-mitochondrial
membranes, and the PARL subfamily, including the mitochondrial rhomboids which play
a role in mitochondrial membrane dynamics at the IM. Rhomboid proteases have been
found in a broad range of species, from bacteria to human.
The rhomboids in both subfamilies exist as a typical structure of sixtransmembrane alpha-helices (TMH) with the highly conserved catalytic serine residue
found in TMH-4 forming a hydrogen bond to a histidine residue in TMH-6. (Figure 1.4)
RHO subfamily members, have an additional TMH at the C-terminus to form a ‘6+1’
structure, while those in the PARL subfamily have the additional TMH at their Nterminus generating a ‘1+6’ structure [12]. The additional TMH is presumed to form the
structure regulating substrate recognition and cleavage, but there is no evidence
supporting this suggestion [47]. The function and structure of the 7th TMH therefore
remains unclear.

Figure 1.4

Rhomboid six-transmembrane helices (TMH).
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PARL and PCP1: identification, function, substrates; similarities and differences
The PARL family is a subfamily of eukaryotic rhomboids that localize to
mitochondria. Parl, for presenilin associated rhomboid like protein, was first identified
through a yeast two hybrid screen aimed at finding the protease contributing to AβPP (γsecretase) intra-membraneous cleavage in Alzheimer’s research [12]. Initially it was
thought that Parl associated with presenilin to cleave AβPP, however later research
showed Parl was a rhomboid protease and was not a functional partner of presenilin.
Functions ascribed to Parl family members to date include regulating mitochondrial
dynamics and cellular apoptosis [12].
In yeast, the Parl family member is encoded by PCP1 (processing of cytochrome
c peroxidase). Pcp1p was the first mitochondrial enzyme of this class of serine peptidase
identified [7]. It is localized to the mitochondrial inner membrane [8, 19] where it has
been shown to catalyze the cleavage of two substrates, Ccp1p and Mgm1p.
The first Pcp1p substrate identified was cytochrome c peroxidase, Ccp1p, an
intermembrane space protein required for peroxide and toxic radical removal. In the
study of Ccp1p processing by K. Esser and B. Tursun, the mAAA protease Yta10/12 was
shown to mediate the first cleavage of Ccp1p, while the rhomboid protease, Pcp1p, was
found responsible for the second cleavage of Ccp1p [3].
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Figure 1.5

Schematic representation of the processing of Ccp1p.

Numbers indicate amino acid position, the cleavage sites. Pcp1p and m-AAA cleavage
sites are indicated by arrows. pCcp1, precursor form of Ccp1p. iCcp1, intermediate form
of Ccp1p. mCcp1, mature form of Ccp1p [3].
The second Pcp1p substrate is Mgm1p (mitochondrial genome maintenance), a
dynamin-related GTPase. Mgm1p is critical for the fusion of the mitochondrial outer
membrane, maintenance of mtDNA, formation of normal inner membrane structures, and
inheritance of mitochondria. Mgm1p exists as two isoforms denoted, l-Mgm1p and sMgm1p. To identify the protease responsible for generating the s-Mgm1p isoform, M.
Herlan, F. Vogel and et al. analyzed Mgm1 processing in different yeast deletion
mutants. They found that the s-Mgm1p isoform was absent in theΔpcp1 mutant,
indicating that Pcp1p is responsible for the second cleavage of Mgm1p [9].
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Figure 1.6

Schematic representation of the N-terminal region of Mgm1p.

Numbers indicate amino acid position. Pcp1p and MPP cleavage sites are indicated by
arrows. MTS, mitochondrial targeting signal. TM, transmembrane domain. RCR:
rhomboid cleavage region.
PCP1 codes for a 346 amino acid protein with an N-terminal mitochondrial
targeting signal, 7 predicted transmembrane helices and an active site motif that include
S256 in TMH-4 and H313 in TMH-6 [2, 3, 12]. The structure of Pcp1p in the inner
membrane has not been clearly demonstrated. According to R.B. Hill [12], Pcp1p belongs
to Parl family with a core 6TMH structure (a.a. 143~331) and an additional TMH
(comprised of amino acids 106~124). The Philius Transmembrane Prediction in Yeast
Resource Center predicts only a 6 TMH (a.a. 102~327) organization. Both of these
predictions were used to predict a possible Parl structure [47] given below (Figure 1.7).
Deletion of pcp1 results in loss of mtDNA, cell respiratory deficiency and mitochondrial
fragmentation; defects similar to mgm1 mutants, suggesting that Mgm1p is a key
substrate of Pcp1p protease activity [19].

13

Figure 1.7

Diagram of putative TMHs of Pcp1p.

Numbers indicate amino acid position. The blue highlights indicate the additional TMH
at N-terminus while the yellow highlights indicate the predicted TMH1-6 regions of
Pcp1p.
The human Parl protein is composed of 379 amino acids and localizes to the
mitochondrial inner membrane with a similar predicted structure as Pcp1p. Unlike Pcp1p,
the N-terminus of Parl has two consecutive cleavages, α and β cleavage by MPP
(mitochondrial processing peptidase) and IMP (inner membrane peptidase) to generate
the mature Parl (R. Hill, 2010). The α cleavage removes the mitochondrial targeting
sequence, while the β cleavage liberates Pβ, a nuclear targeted peptide.. Parl mutant L79E
is β cleavage resistant, so is the deletion mutant Δ75-79 confirming the location of the β
cleavage site [47]. The function of these two cleavages remains unclear. Parl knockout
mice suffer from massive atrophy, cells lacking Parl were more sensitive to inducers of
apoptosis and Parl influenced the cristae remodeling controlled by Opa1 [43, 44].
Although human OPA1 is the ortholog of yeast MGM1, no evidence has been found to
show that Opa1 is a substrate for Parl. To date, the proven substrates of Parl activity
include Omi/HtrA2 and Pink1, PTEN-induced kinase-1. Pink1 is one of the
mitochondrial proteins responsible for recessively inherited Parkinson’s disease (PD)
[55]. One mutation in Parl (230G>A, p Ser77Asn) has been recently identified in PD
patients but none of the controls [54]. This is the only identified mutation in Parl that has
14

been linked to a human disease. Statistical analysis identified an additional mutation that
localizes to the Parl promoter region, T191C, which appears to have a significant impact
on mitochondrial content [56].
According to Blast protein software, Pcp1p and Parl share only 18% amino acid
identity (Figure 1.8).

Figure 1.8

Comparison of the 6TMH of Pcp1p and Parl.

Numbers indicate amino acid position. Yellow highlights indicate typical structure
TMH1-6; Blue highlights indicate the conserved GxxxG motif found in both proteins;
Gray highlights show the GxxxG motif found in only one of the two proteins.
The transmembrane domains are more conserved than matrix loops. The GxxxG
motif is important for transmembrane helices association and structure stabilization, and
it is the most frequent motif in transmembrane proteins [57]. Four such motifs are found
in the 6 TMH domains of Pcp1p, two of which are conserved with Parl. The GxxxG in
TMH-6 (Pcp1p: G316 and G320; Parl: G388 and G342) are conserved in all rhomboids
[47]. Interestingly, despite only sharing18% amino acid identity, both Pcp1p and Parl
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adopt a similar 6TMH structural organization and the mitochondria fragmentation detect
in the Δpcp1 mutant can be rescued by the expression of Parl [19].
Using yeast system for study
S. cerevisiae has been used as the model system for molecular biology research
for years. Dr. Hartwell used S. cerevisiae as a model system for studying cancer and the
cell cycle and received a Noble Prize in 2001 for his discovery of cyclins and CDKs, key
regulators of cell cycle progression [45]. Yeasts have also successfully been used to
identify protein-protein interactions using two-hybrid screens [40], as well as genes that
are important for damage recovery pathways [46].
The complementation of many yeast gene deletion mutants with their
corresponding human homologs suggests a conserved role between the activities of these
two organisms [19]. Saccharomyces cerevisiae has a completely sequenced genome, and
single gene deletion mutants are commercially available or can be easily generated. In the
laboratory, budding yeast have a short generation time of about 90 min. Furthermore,
there are many established protocols for studying the regulatory mechanism of
mitochondrial biogenesis in this system. Together, these make S. cerevisiae an ideal
model organism for our studies focused on mitochondria and mitochondrial-based
molecular mechanisms.
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CHAPTER II
GOAL AND EXPERIMENTAL DESIGN

We propose that Pcp1p exists in a multi-protein complex with proteins of the
mitochondrial inner membrane. These proteins may associate with Pcp1p to modulate
Pcp1p activity, or influence substrate specificity. The goal of my research is to use a
genetic approach to generate and then characterize Pcp1p temperature sensitive mutations
with the goal of identifying domains that are essential for Pcp1p peptidase activity.
Ultimately, these temperature sensitive strains will be used in an over-expression
suppressor screen for the isolation of Pcp1p interacting proteins with the long-term goal
of confirming a functional link between Pcp1p and components of the inner membrane
translocation machinery. Future biochemical characterization will help solidify this
proposed linkage between protein import and mitochondrial morphology.
Temperature sensitive mutants usually result from generating thermo labile
proteins which exhibit temperature dependent defects in protein folding, assembly, or
synthesis. The temperature under which the mutants are able to grow and proteins
function properly is called the ‘permissive temperature’ while the temperature at which
the mutants are unable to grow is referred to as the ‘non-permissive temperature’. For a
temperature sensitive mutant screen, all candidates would initially be grown at the
permissive temperature followed by parallel growth at different temperatures. The strains
that exhibit deficient growth phenotypes at these different temperatures are considered
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temperature sensitive strains. Since in the genetic background used in these studies,
Pcp1p is essential for grown on nonfermentable carbon, a temperature sensitive screen
was designed whereby mutations that negatively impacted Pcp1p activity were identified
by absence of growth on nonfermentable carbon at nonpermissive temperature.
Hydroxylamine was used to randomly mutagenize pDG295 which contains the
PCP1 gene under the PCP1 promoter on a HIS3 marked plasmid. The mutagenized
plasmids were transformed into a PCP1 shuffle strain for initial identification of clones
with an altered temperature sensitivity profile. The PCP1 shuffle strain has the genomic
copy of PCP1 deleted but carries a wild type copy of PCP1 on a URA3 marked plasmid.
Since the URA3 marker can be counter selected by growth on 5FOA, a pcp1 strain can
easily and quickly be generated. Under these conditions the functionality of the
mutagenized PCP1 plasmid can be determined (Figure 2.1).

Figure 2.1

Schematic of the screen used to identify pcp1 temperature sensitive
mutants.
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Putative temperature sensitive clones were analyzed by 10X serial dilution to
further characterize the temperature sensitivity profile. All positive clones were processed
for plasmid isolation and the isolated plasmid transformed into E. coli for amplification.
The isolated plasmids were used for two purposes. The first was for the sequencing of
the PCP1 open reading frame to identify nucleotide mutations. For this, nine PCP1
specific primers were designed to generate overlapping sequencing data for both the
PCP1 promoter region and the PCP1 open reading frame (Figure 2.2). Second, the
plasmids were transformed into the original PCP1 shuffle strain and into a second PCP1
shuffle strain that contained an epitope tagged version of Mgm1p (DGY321). These
strains were used to confirm the initial temperature sensitive phenotype and to determine
the impact the isolated mutation had on Mgm1p substrate processing. Strains were
further tested for Pcp1p expression levels, and Pcp1p processing of Ccp1p.

Figure 2.2

Primers used for PCP1 sequencing.

Nine primers that anneal to sequences throughout PCP1 were used to ensure overlapping
sequence information was obtained.

19

To analyze changes in mitochondrial morphology, staining was carried out using
mitochondrial dyes (Mito Tracker Orange CMTMRos). Mito Tracker Orange CMTMRos
accumulates in mitochondria in living cells based on membrane potential and retained
after fixation. Changes in mitochondrial morphology, as determined by microscopic
methods, were correlated to changes in Pcp1p activity as measured by Western blot
analysis of Mgm1p and Ccp1p processing.
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CHAPTER III
MATERIALS AND METHODS

All strains, plasmids, primers, media, and reagents used in this study are listed in
Appendix A.
Hydroxylamine mutagenesis of PCP1 plasmids
The plasmids pDG295 and pDG331 (500ng), containing the PCP1 open reading
frame under the endogenous PCP1 promoter in pRS413, were mutagenized by treatment
with 1M hydroxylamine hydrochloride in 0.45M sodium hydroxide for 20 and 25 hours
at 37˚C [31]. The reaction was stopped with purification of the plasmid using the Qiagen
miniprep kit according to the manufacturer’s instructions.
Yeast transformation and initial screening
Yeast transformations were carried out as described [22]. Briefly, cells were
grown in YPD or selective media at 30˚C with shaking until they reached an OD600 of 0.5
– 0.6. Cells were harvested by centrifugation at 1,750 xg for 10 min at 4˚C, and the
resulting cell pellet resuspended in 0.1M LiAc-TE at a volume of 50µl for each 10mls of
original cell culture. To each 50µl aliquot, 330µl of 40% PEG3000 in 0.1M LiAc-TE, 10µl
of 5mg/ml sheared-salmon sperm DNA, and 1-10µl of sample DNA were added.
Samples were maintained at 30˚C for one hour followed by a 10-min incubation at 42˚C.
Cells were plated to selective plates and placed at the indicated temperatures.
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For selective screening, the mutagenized plasmid was transformed into our pcp1
shuffle strain, DGY43, which contained the PCP1 covering plasmid pDG103.
Transformants from -Ura -His plates were replica printed to -His 5FOA (0.1% 5Fluoroorotic acid) plates to eject the covering URA3 marked PCP1 plasmid. After 2 days
of growth, plates were replica printed to four plates: -His glucose at 30˚C, -His E/G
(Ethanol/Glycerol) at 30˚C, -His E/G at 37˚C, and -His E/G at 18˚C. Putative mutants
were colonies that were unable to grow on ethanol/glycerol plates at 37˚C or 18˚C after
3-5 days.
Plasmid isolation from yeast and bacteria and DNA sequencing
To isolate plasmids from yeast, cultures were grown overnight at 30˚C in 5ml of
selective media. Samples were centrifuged at 21,130 xg at room temperature for 1 min
and the supernatant was removed by aspiration. Cell pellets were resuspended in 500µl of
100mM Tris pH 9.0 and incubated at 30˚C 10 min. Cell were re-isolated by
centrifugation and cells pellets were resuspended in 200µl of freshly made spheroplast
buffer (1M Sorbitol, 20mM Tris pH 7.5, 10mM EDTA pH 8.0; 0.15μg/μl 100T
Zymolyase, and 0.2% β mercapto-ethanol). Cells were incubated in spheroplast buffer for
one hour at 30˚C and re-isolated by centrifugation at 2,000 xg for 10 min. Cells were
resuspended in 250μl of Qiagen P1 buffer (50 mM Tris-Cl, pH 8.0, 10mM EDTA,
100μg/ml RNase A) and subjected to two rounds of freeze-thaw cycles. An amount of
glass beads equivalent to ~100μl was added and samples underwent 5 cycles of 30
second vortexing followed by a 30 second incubation on ice. 250μl of P2 buffer (200mM
NaOH, 1% SDS w/v) was added, samples were incubated at room temperature for 5 min,
followed by the addition of 350μl of N3 buffer (3.0 M potassium acetate, pH 5.5). The
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lysate was centrifuged at 21,130 xg for 10min, the supernatant transferred to a new
eppendorf tube, and plasmid DNA precipitated with the addition of 0.6 volumes of 100%
isopropanol. The DNA was isolated by centrifugation at 21,130 xg for 15min at 4˚C,
washed with 70% ethanol, air dried, and resuspended in 30µl of water. 4-10µl of isolated
plasmid was transformed into NEB Turbo competent E.coli following the manufacturer’s
instructions (New England Biolabs). The resulting plasmids were isolated from E. coli
using the Qiagen Plasmid Mini DNA kit.
For Sanger sequencing, 150ng of plasmid and 20ng of primer (M13F, M13R,
DG11, DG86, DG179, DG180, DG181, DG182, DG183) were used. All sequencing
services were provided by the DNA Laboratory at Arizona State University.
Serial dilution assay
Cells were grown in -His media until an OD600 of 0.5 to 0.6. A volume equivalent
to 1x107 cells was harvested by centrifugation and the cell pellet resuspended in 100μl
water to achieve 1x105 cells/µl. Cells were 10-fold serially diluted in a 96 well microtiter
plate to reach 100 cells/µl final. For each dilution, 2μl of cells were spotted onto selective
plates and incubated at the indicated temperatures for 3-5 days.
Site directed mutagenesis
The T962C nucleotide mutation (corresponding to nucleotide position 962 of the
PCP1 open reading frame) was corrected using either the Agilent Quick Change II Kit or
the Invitrogen GeneArt® Site-Directed Mutagenesis Kit, with primers DG184
(5’GGTGGCTCTATGGGGGTCTTGTACGGAGG3’) and DG185
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(5’CCATCCGTACAAGACCCCCATCATAGAGCCACC3’). All corrections were
confirmed by sequencing.
Generating Mgm1p HA3 and Ccp1p HA3 tagged strains
Homologous recombination was used to integrate the HA3 epitope tag inframe
with the 3’ end of MGM1 in our PCP1 shuffle strain, DGY43. The corresponding DNA
fragment was generated by PCR with primers DG100 and DG101 using plasmid pDG266
(pFA6a-HA3-KanMx6) as the template [26]. Transformed colonies were selected on YPD
plates supplemented with 0.2g/L G418 and large colonies were examined by PCR
analysis using genomic DNA as the template [24] and primers DG18 and DG108.
Western blot analysis was used to confirm protein expression of the epitope tagged
protein.
A similar strategy was used to integrate the HA3 epitope tag inframe with the 3’
end of CCP1 in DGY11 except that the PCR product was generate using primers DG186
and DG187. Primers DG18 and DG188 were used to confirm correct integration using
genomic DNA as the template.
Generating a pcp1 shuffle strain with epitope tagged substrate proteins
DGY321 (a ura3Δ0, leu2Δ0, his3Δ1, met15Δ0, γpcp1::LEU2, MGM13XHA::Kanr pDG103) and DGY322 (α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, CCP13XHA::Kanr) were mated by crossing on YPD. After 2 days at 30˚C, colonies were
streaked onto -Leu, -Ura, -Met plates to select for diploid cells. Colonies were then
transferred to sporulation plates, and after 5 days, tetrads were micro-dissected onto fresh
YPD plates. Four spore tetrads were further analyzed on selective plates (-Leu, -Met,
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-Lys, -Ura, and YPD with 0.2g/L G418) to identify a strain containing the URA3
covering plasmid, the HA3 tagged CCP1 and MGM1 (Kanr), and γpcp1::LEU2. To
determine the mating type, the strains were crossed with both 17α and 14a mating type
tester strains on to lawn plates, followed by replica printing onto SDmin plates the next
day. Western blotting using antibodies to the haemagglutinin tag was used to confirm that
epitope tagged versions of both Mgm1p and Ccp1p were present.
Western blot analysis
Cells were grown at 30˚C in selective media until reaching an OD600 of 0.5 to 1.0.
A volume of cells equivalent to 1-2 OD600 was harvested by centrifugation. Total cellular
protein was extracted by alkaline lysis as described [49]. Proteins were separated by
electrophoresis through a 7%, 8%, or 12% SDS polyacrylamide gel, transferred to
nitrocellulose, and probed with antibodies to the HA epitope (Convance) or Ccp1p (gift
from D. Pain, UMDNJ) followed by HRP conjugated secondary antibodies (GE
Healthcare). The membranes were developed using Pierce ECL Western Blotting
Substrate (Thermo Scientific).
Mitochondrial staining
Mito Tracker Orange CMTMRos (Invitrogen, M7510) is a functional dye in that
it stains active mitochondria in living cells and is retained after fixation. When this
functional dye enters a cell, it accumulates in the negatively charged mitochondrial
matrix due to the membrane potential across the inner membrane. The resulting
fluorescent signal is used to determine the general structural organization of
mitochondria.
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1 ml of log-phase cells (0.5 to 0.8 OD600) were transferred to a dark eppendorf
tube and cells pelleted by centrifugation at 5000 xg for 5 min at room temperature. Media
was removed by aspiration and the cell pellet resuspended in 1.5ml of selective media
with 300nM Mito Tracker Orange CMTMRos. Cells were incubated in a 30˚C water
bath for 30 min, followed by 1XPBS wash. Cells were fixed in 3.7% formaldehyde for
20 min before microscopy. Images were captured on a Nikon Eclipse-50i using
QCapture Pro software with a Texas Red filter for visualizing Mito Tracker Orange.
Exposure settings were the same for all strains. All cells were scored as either tubular or
fragmented. A single cell containing 4 or more discrete spots was considered fragmented,
otherwise, cells were scored as having a tubular network. 220-340 cells were scored for
each strain.
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CHAPTER IV
RESULTS AND DISCUSSION

Mutagenesis and initial screening
To generate random mutations in PCP1, the plasmid pDG295 containing the
PCP1 gene under the PCP1 promoter with a HIS3 selective marker was exposed to
hydroxylamine for 20 to 25 hours. Hydroxylamine will change nucleotides outside of
PCP1, however these changes are unlikely to negatively impact the screen although they
may interfere with the downstream selection and/or amplification of the plasmid in
E.coli.
Mutagenized plasmid was transformed into the PCP1 shuffle strain (DGY43)
following standard yeast transformation protocols [22]. Transformants were plated on
-His/-Ura media to ensure that only strains that have both plasmids (the wild type
covering PCP1 plasmid and the hydroxylamine treated test PCP1 plasmid) would grow.
The resulting colonies were transferred to -His/5FOA plates by replica printing to select
against the URA3 marked wild-type PCP1 plasmid. Taking this approach, colonies from
-His 5FOA plates will contain only the mutagenized plasmid (Figure 4.1).
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Figure 4.1

Diagram of plasmid mutagenesis and initial screening in yeast

Yeast cells deleted for PCP1 are unable to grow on plates containing
nonfermentable carbon such as ethanol or glycerol (E/G) as their sole carbon source
(Figure 4.2) [9]. We took advantage of this growth phenotype to identify temperature
sensitive alleles of PCP1. -His 5FOA plates were replica printed to -His glucose and -His
E/G plates at 18˚C, 30˚C, and 37˚C. Colonies were selected that grew on E/G plates at
30˚C but not at 37˚C and/or 18˚C. Since functional Pcp1p is required for growth on
nonfermentable carbon, this selection method screens against all mutations that generate
nonfunctional PCP1 alleles.
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Figure 4.2

Growth profile of PCP1 and Δpcp1 mutant on fermentable and nonfermentable media

WT: PCP1 shuffle strain containing a HIS3 markered PCP1 plasmid. Δpcp1: PCP1
shuffle strain containing an empty HIS3 plasmid. Both strains were grown on -His 5FOA
(0.1% 5-Fluoroorotic acid) plates to eject the covering URA3 plasmid. A 10X serial
dilution is shown.
On average 1,410 to 14,600 colonies were screened at one time for a total of
approximately 32,000 colonies (Table 4.1). Three rounds of screening were carried out
using mutagenized plasmid pDG295 (PCP1 T962C) while two round were performed for
mutagenized plasmid pDG331 (PCP1). For these initial rounds of screening, 58 out of
32,690 colonies were identified as having a temperature sensitive phenotype. In addition
to temperature sensitive mutants, the screen identified petite mutants, due to mutations
that generated nonfunctional Pcp1p alleles. Out of the 32,690 colonies screened, 173
were classified as petites
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Summary of temperature sensitive mutant screening

Results from 5 independent transformation events for temperature sensitive PCP1 alleles. Low temperature sensitive: strains
grow on E/G at 30˚C and 37˚C, but not at 18˚C. High temperature sensitive: strains grow on E/G at 30˚C and 18˚C, but not at
37˚C. Poor growth temperature sensitive: the mutants show similar pattern of slow growth on E/G under all temperatures.
Petites: no growth on nonfermentable carbon and very tiny colonies on –His glucose plates.

Table 4.1
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Serial dilution testing
To eliminate strains that grew poorly due to the acquisition of random genomic
mutations and not plasmid-based mutations, all putative clones were further screened for
growth defects. This step is important as it is known that a small percentage of cells in a
given culture will spontaneously acquire mutations that result in the lack of growth on
nonfermentable carbon giving rise to cells with a petite phenotype [16].
To identify this class of mutants, cells from the original transformation plate were
patched onto –Ura and –Ura E/G plates. Growth on media lacking uracil ensures that the
strains retain the WT PCP1 covering plasmid. Therefore, under these conditions if a
strain is unable to grow on ethanol/glycerol, it can be presumed that it has acquired a
genomic mutation resulting in the observed petite phenotype. Forty petites out of 146 fell
into this category and were dropped from the study. Strains that did grow on –Ura E/G
were patched onto –His/5FOA to eliminate the URA3 covering plasmid and subsequently
patched onto –His and –His E/G plates. Strains that grew on –His but not –His E/G likely
have a mutation that generates a Pcp1 protein that is either not expressed, degraded, or
nonfunctional. Using this screening strategy, 76 strains fell into this category. Strains
with altered growth profiles on –His E/G fell into the third category of mutants: putative
temperature sensitive mutants.
To confirm temperature sensitivity, a serial dilution assay was carried out.
DGY361 (WT PCP1) and DGY362 (Δpcp1) were used as positive and negative control
strains, and all tested mutants were spotted to –His media and –His E/G media at
different temperatures (Figure 4.3). Each row represents one strain 10 fold serially diluted
from 105 cells/µl to 1 cell/µl.
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Figure 4.3

Screening candidate ts mutants by serial dilution testing

Strain nomenclature: TS refers to temperature sensitive, 25 or 20 stands for the number of
hours the plasmid was treated with hydroxylamine, and the numbers after the dash are the
serial number within the batch. (a, b) TS25-1~TS25-3, the three low TS mutants; TS254~TS25-9, the 6 high TS mutants, TS25-10, the Poor growth TS in batch 1; (c) TS20-1,
the low TS; TS20-5 and TS20-6, high TS in batch 2; TS20-29 and TS20-30, Poor growth
TS; (d) HTS20-13 and LTS20-5 from batch 3.
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Serial dilution testing of candidate temperature sensitive mutants showed that
mutant TS25-2 exhibited a growth defect on E/G plates at 30˚C and 37˚C, TS25-3, TS206, and HTS 20-13 showed deficient growth on nonfermentable media at higher
temperatures while mutants TS20-1, TS20-29, TS20-30, and LTS20-5 showed deficient
growth on nonfermentable media at lower temperatures.
Plasmid isolation and sequencing results
To identify the mutations within PCP1 responsible for the observed ts phenotype,
plasmids were isolated from candidate yeast mutants as described by Hoffman and
Winston [24] and then transformed into E.coli for amplification and template preparation
for sequencing.
We were unable to recover plasmids in E. coli for several strains possibly due to
mutations in required bacterial elements (i.e. selectable marker, origin of replication). In
total, seven out of thirty-seven TS mutants and eighteen out of thirty-eight petites were
lost at this step (Table 4.2).
Table 4.2

Mutant plasmids isolated from yeast.

Batch

Total # of colonies
screened

1
2
3
Total

14,600
5,000
8,080
27,680

TS
Serial dilution*/plasmid
isolation#
2/1
5/5
30/24
37/30

Petites
Serial dilution*/plasmid
isolation#
28/11
10/9
38/20

* The number of confirmed mutants by serial dilution (batch1, batch2, and batch3);
#
The number of mutants whose plasmid was successfully isolated
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Isolated plasmids were confirmed pRS413-based by restriction digestion prior to
sending the plasmid for sequencing (Arizona State University). For the first two rounds
of screening, 6 of the TS candidates and 20 of the petites were sequenced and the results
are shown in Table 4.3 below. For the third round candidates, six isolated plasmids were
sequenced as these six maintained their TS phenotype when transformed back into the
parental yeast strain (DGY43). The petites in the third round of screening will be
analyzed in future studies.
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Table 4.3

Sequencing results of petites
Strain #

Nucleotide mutations in PCP1 Corresponding amino acid changes

EG 25-1

G228A; T962C

W76STOP; V321A

EG 25-2

C526T; T962C

Q176STOP; V321A

EG 25-5

G501A; T962C

R167R; V321A

EG 25-6

G944A; T962C

G315D; V321A

EG25-13

C764T; T962C

A255V; V321A

EG 25-16

C298T; T962C

Q100STOP; V321A

EG 25-23

C298T; T962C

Q100STOP; V321A

EG 25-24

C481T; T962C

Q161STOP; V321A

EG 25-25

G228A; G763A; T962C

W76STOP; A255T; V321A

EG 25-26

G959A; T962C

G320E; V321A

EG 25-27

C526T; T962C

Q176STOP; V321A

EG 20-1

C920A; T962C

S307STOP; V321A

EG 20-2

C295T; C592T; T962C

Q99STOP; H198Y; V321A

EG 20-3

C292T; T962C

Q98STOP; V321A

EG 20-4

C295T; T962C

Q99STOP; V321A

EG 20-5

C441G; T962C

W147STOP; V321A

EG 20-7

C580T; T962C

Q194STOP; V321A

EG 20-8

T728 X; C731G; T962C

Frame shift; V321A

EG 20-9

C232T; G925T; T962C

G108S; D309W; V321A

EG 20-10

G717A; T962C

W239STOP; V321A

Strain nomenclature: EG indicates that the plasmid was unable to support growth on
Ethanol/Glycerol. 25 or 20 indicate the number of hours the plasmid was treated with 1M
hydroxylamine. The number after the dash is the serial number within the batch. Only the
petites from the first two rounds of screening were examined. The location of the
mutations followed by the exact nucleotide changes and the corresponding amino acid
changes are shown.
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Table 4.4

Sequencing results of temperature sensitive mutants
Strain # Nucleotide mutations in PCP1Corresponding amino acid changes
TS 25-2

G755A; T962C

S252N; V321A

TS 20-1

G755A; T962C

S252N; V321A

TS 20-5

T962C

V321A

TS 20-6

T962C

V321A

TS 20-29

G358A; T962C

G120R; V321A;

TS 20-30

G755A; T962C

S252N; V321A

HTS 20-1

T962C

V321A

HTS 20-2

T962C

V321A

HTS 20-4

T962C

V321A

HTS 20-5

T962C

V321A

HTS 20-13

G697A; T962C

G233S; V321A

LTS 20-5

G698A; T962C

G233D; V321A

Strain nomenclature: TS refers to temperature sensitive, 25 or 20 stands for the hours the
plasmid was treated with hydroxylamine, and the numbers after the dash are the serial
number within the batch. HTS refers to high temperature sensitive from the 3rd batch.
The locations of the mutations followed by the exact nucleotide changes and the
corresponding amino acid changes are shown.
Sequencing results (Tables 4.3 and 4.4) confirm that hydroxylamine generates C
to T and G to A mutations. In addition, all clones had a T962C mutation suggesting that
the original plasmid used for hydroxylamine mutagenesis likely contained this mutation.
Careful resequencing of the pDG295 plasmid confirmed this finding. Since the T962C
mutation may interfere with the screening process, the nucleotide was corrected by site
directed mutagenesis to generate plasmid pDG331. The T962C mutation was
subsequently corrected in most mutants generated to date.
To confirm that the identified mutation gave rise to genuine ts pcp1 allele,
sequenced plasmids were transformed to PCP1 shuffle strain and retested by 10X serial
dilution (Figure 4.4) In some cases, the temperature sensitive phenotype was lost upon
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plasmid retransformation and serial dilution testing. This appeared to be the case for the
originally isolated T962C mutation (TS20-5, TS20-6, etc.). It is likely that the mutation
that resulted in the temperature sensitive phenotype was not in PCP1, but rather a
randomly acquired genomic mutation.

Figure 4.4

10X serial dilution of sequenced ts mutants.

Isolated plasmids from TS mutants identified in the first two rounds of screening were retransformed into theΔpcp1 shuffle strain and the resulting temperature sensitive
phenotype retested.
To summarize, four temperature sensitive mutants with different nucleotide
changes in PCP1 were identified. In addition, screening of 20 petite mutants identified
four amino acids that are individually required for Pcp1p activity (Table 4.5).

37

Table 4.5

Putative mutants with dysfunctional Pcp1p

TS 20-1

Nucleotide mutations in
PCP1
G755A; T962C

Corresponding amino acid
changes
S252N; V321A

partially functional

TS 20-29

G358A; T962C

G120R; V321A

partially functional

HTS 20-13

G697A; T962C

G233S; V321A

partially functional

LTS 20-5

G698A; T962C

G233D; V321A

partially functional

EG 25-6

G944A; T962C

G315D; V321A

Nonfunctional

EG 25-13

C764T; T962C

A255V; V321A

Nonfunctional

EG 25-26

G959A; T962C

G320E; V321A

Nonfunctional

EG 20-9

C232T; G925T; T962C

G108S; D309W; V321A

Nonfunctional

Strain #

Pcp1p function

TS 20-1, TS20-29, HTS 20-13 and LTS 20-5 are temperature sensitive mutants identified
from the first three rounds of screening. All EG strains are petites identified from the first
2 rounds of screening.
Site directed mutagenesis of pDG295 and putative mutants
To confirm the impact the identified mutations have on Pcp1p activity, site
directed mutagenesis was used to correct the T962C and the resulting phenotype was
retested. To date, three mutants remain to be corrected. One of these contains a G959A
mutation, which because of its proximity to the T962C mutation, would also be altered if
the same site directed mutagenesis approach was taken.
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Table 4.6

Corrected mutant plasmids by site directed mutagenesis

Strain #

Plasmid

Nucleotide mutations in PCP1

Corresponding amino acid changes

pDG295 SDM5

pDG331

None

None

TS 20-1 SDM2

pDG338

G755A

S252N

TS 20-29 SDM6

pDG345

G358A

G120R

LTS 20-5 SDM2

pDG346

G698A

G233D

EG 25-6 SDM3

pDG351

G944A

G315D

EG 20-9 SDM2

pDG350

C232T; G925T

G108S; D309W

SDM stands for site directed mutants, and the number indicates the candidate colony
from the transformation plate.
Pcp1p expression levels
To determine whether the amino acids changes identified had an impact on Pcp1p
stability, steady state protein levels for Pcp1p were measured by Western blot analysis.
To this end, the HA3 epitope was replaced with HA9 to generate PCP1:HA9. The addition
of extra haemagglutinin epitopes to Pcp1p enabled Pcp1p detection in total cell lysate by
western blot analysis. To date this swap has been carried out for wild-type Pcp1p and six
Pcp1p mutants: S252N, G120R, G233D/V321A, G233S/V321A, G108S/D309W,
G315D, and G320E/V321A. When compared to wild-type Pcp1p levels, some of the
strains with plasmid borne mutant pcp1 had similar overall Pcp1p expression levels while
other mutants had lower expression levels (Figure 4.5). However all mutants exhibited
Pcp1p expression suggesting that the phenotype of these pcp1 mutants was not a result of
a loss in Pcp1p protein levels.
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Figure 4.5

Western blot analysis of Pcp1p in HA9 tagged strains

Lane 1, PCP1-9xHA; lane 2, MGM1-3xHA, PCP1-3xHA; lane 3, negative control,
GPDprom-PCP1; lane 4, PCP1-9xHA (S252N); lane 5, PCP1-9xHA (G120R); lane 6,
PCP1-9xHA (G233D V321A); lane7, PCP1-9xHA (G233S V321A); lane 8, PCP19xHA (G108S D309W); lane 9, PCP1-9xHA (G315D); lane 10, PCP1-9xHA (G320E
V321A). Proteins were isolated by alkaline lysis, run out on 12% SDS PAGE, transferred
to nitrocellulose, and then probed with α-HA antibodies (Convance) followed by HRP
conjugated secondary antibodies (GE Healthcare) [27].
To determine whether the HA9 epitope tag had any effect on Pcp1p activity, a
serial dilution assay was carried out to compare the growth phenotype of strains with HA3
tagged Pcp1p to HA9 tagged Pcp1p. No significant differences in growth were detected
(Figure 4.6).

Figure 4.6

Growth profile of HA3 and HA9 tagged PCP1 strains
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Western blot analysis was used to determine differences in the processing of
Ccp1p for strains expressing HA3 and HA9 tagged Pcp1p.

Figure 4.7

Western blot analysis of Ccp1p processing: comparing HA3 and HA9
tagged Pcp1p

Lane 1, WT; lane 2, Δccp1; lane 3, Δyta10/12; lane 4, PCP1-3xHA; lane 5, PCP19xHA; lane 6, PCP1-3xHA (G233D V321A); lane 7, PCP1-9xHA (G233D V321A); lane
8, PCP1-3xHA (G120R); lane 9, PCP1-9xHA (G120R); lane 10, PCP1-3xHA (S252N);
lane 11, PCP1-9xHA (S252N). All samples are from the same gel.
In wild type S. cerevisiae, Ccp1p is processed to the mature form (Figure 4.7,
lane 1) while strains deleted for subunits of the m-AAA protease result in precursor
Ccp1p accumulation (Figure 4.7, lane 3). As shown in lanes 4 and lane 5, HA3 and HA9
tagged PCP1 showed no difference in Ccp1p processing. Although all Pcp1p mutants
showed a deficiency in Ccp1p processing, the longer HA epitope appeared to exacerbate
this defect. Given these findings, Pcp1p activity studies will use the HA3 tagged version
of PCP1 instead of HA9.
The effect of mutant pcp1 on Mgm1p processing
To analyze Mgm1p processing in pcp1 mutant strains, homologous recombination
was used to integrate the HA3 epitope tag inframe with the 3’ end of MGM1 in our PCP1
shuffle strain, DGY43 [26]. Colonies were selected on YPD-G418 plates and large
colonies were examined by genomic PCR analysis to confirm correct integration. To
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confirm the HA3 epitope tag was inframe and did not interfere with Mgm1p expression or
processing, an anti-HA antibody was used to detect the HA3 tagged Mgm1p by western
blot analysis (Figure 4.8). The resulting PCP1 shuffle strain with MGM1:HA3 is referred
to as DGY321.
Plasmids pDG331, pDG96, pDG295, pDG338, pDG315 were transformed into
DGY321, and the covering PCP1 plasmid was ejected by growth on 5FOA containing
plates. An equal number of cells were processed by alkaline lysis for Western blot
analysis to measure Mgm1p processing.

Figure 4.8

Western bolt analysis of Mgm1p processing

Lane 1, positive control, PCP1; lane 2, Δpcp1; lane 3, PCP1 (V321A); lane 4, PCP1
(S252N); lane 5, PCP1 (V321A S252N). Cells equal to 1 OD600 were harvested by
centrifugation and proteins isolated by alkaline lysis. Samples were run out on 7% SDS
PAGE, proteins transferred to nitrocellulose, and probed with αHA antibodies
(monoclonal, Convance) followed by HRP conjugated secondary antibodies (GE
Healthcare) [27]. Antibodies to Pgk1p were used as a control for equal loading.
Pcp1p cleaves half of the long Mgm1p isoform into the short isoform. All pcp1
mutants examined contained both the short and long isoforms of Mgm1p but were also
found to contain an incorrectly processed form of Mgm1p. This is in contrast to the pcp1
deletion mutant that contained only the long isoform and an incorrectly processed
isoform. Analysis using ImageJ showed little cleavage difference between PCP1 WT
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(lane1) and V321A (lane3), while S252N (lane4) and the strain with both mutations
(lane5) had only 57% and 67% of the cleavage activity of the WT PCP1, respectively.
These results suggest that the Pcp1p mutants have reduced peptidase activity against
Mgm1p.
The effect of mutant pcp1 on Ccp1p processing
Although we generated HA3 tagged CCP1 in Δpcp1 strain (DGY335 MGM1:HA3
CCP1:HA3 and DGY334 CCP1:HA3), to simplify the steps for analysis and to ensure
that misprocessing of Ccp1p was not due to the addition of the HA tag, we analyzed
Ccp1p using antibodies generated against the mature Ccp1p protein for western analysis.
Strains DGY6, DGY21, DGY46, DGY43, DGY361, DGY362, DGY388,
DGY400, DGY369 were grown in selective media overnight and an equal number of
cells were processed for Western analysis of Ccp1p processing.

Figure 4.9

Western bolt analysis of Ccp1p processing, plasmid borne mutant pcp1
strains.

Lane 1, WT; lane 2, Δccp1; lane 3, Δyta10/12; lane 4, GPDprom-PCP1; lane 5, PCP13xHA; lane 6, Δpcp1; lane 7, PCP1 (V321A); lane 8, PCP1 (S252N); lane 9, PCP1
(S252N V321A). Cells equal to 1 OD600 were harvested by centrifugation and proteins
isolated by alkaline lysis. Samples were run out on 12% SDS PAGE, proteins transferred
to nitrocellulose, and probed with antibodies to Ccp1p (gift from D. Pain, UMDNJ)
followed by HRP conjugated secondary antibodies (GE Healthcare) [27]. Antibodies to
Pgk1p were used as a control for equal loading.
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The mature Ccp1p is evident in cells expressing WT Pcp1p (lane 1), while cells
lacking m-AAA activity (lane 3) or Pcp1p (lane 6) gave rise to the precursor and
intermediate forms of Ccp1p, respectively. There was only a minor difference in Ccp1p
processing in cells expressing Pcp1p and Pcp1p-HA3 (compare lane 4 and lane 5),
confirming that the HA epitope had little effect on Pcp1p activity. Relative to WT Pcp1pHA3, Ccp1p processing by Pcp1p mutants V321A, S252N, and S252N V321A were 76%,
60% and 71% respectively. Total Ccp1p (intermediate plus mature forms) for Pcp1p
S252N V321A was 31% that of control, while other mutants showed similar amount of
total Ccp1p. These results indicate that in the Pcp1p S252N V321A mutant, Ccp1p was
likely subjected to increased degradation.
Interestingly, our Western blot data suggests that Pcp1p recognition of different
substrate proteins may involve different amino acids. For example, the PCP1 V321A
mutant showed a defect in Ccp1p processing (76% of WT), but had little impact on
Mgm1p processing. We propose that 321valine is important for Ccp1p recognition, and is
less important for Mgm1p recognition.
The Mgm1p and Ccp1p processing differences between the strains tested were
consistent with the growth profile determined by serial dilution testing (Figure 4.10).
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Figure 4.10

10x serial dilution of putative ts mutants.

WT, DGY361, positive control, PCP1-3xHA; Δpcp1, DGY362, negative control;
DGY388, PCP1 V321A; DGY400, PCP1 S252N; DGY369, PCP1 V321A S252N.
Mitochondria staining
To determine the impact these mutations had on mitochondrial morphology,
immunofluorscence microscopy using MitoTracker Orange CMTMRos was performed
(Figure 4.11). All cells were scored as either tubular or fragmented. A single cell
containing 4 or more discrete spots was considered fragmented, otherwise, cells were
scored as having a tubular network. All tested Pcp1p mutations showed partial
fragmentation of mitochondria when compared with WT. Additional studies are required
to better characterize the morphology differences between mutants.
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Figure 4.11

Microscopy of mitochondrial morphology of mutant pcp1 strains.

a) DGY361, WT PCP1-3xHA; b) DGY362,Δpcp1; c) DGY388, PCP1 (V321A); d)
DGY400, PCP1 (S252N); e) DGY369, PCP1 (V321A S252N). 1 ml of log-phase
cells (0.5-0.8 OD600) were labeled with 300nM Mito Tracker Orange CMTMRos.
Cells were fixed in 3.7% formaldehyde for 20 min and all images were captured
using the same exposure settings. Images were captured using a Texas Red filter
with QCapture Pro software.
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CHAPTER V
SUMMARY AND FUTURE DIRECTIONS

In this study, over 32,000 colonies have been screened and eight mutants with
different nucleotide mutations in PCP1 have been identified, indicating that the random
transition mutations generated by hydroxylamine was a practicable approach (Table 4.5).
Four of the eight mutants were petites, exhibiting no growth on nonfermentable media,
and contained either single or double amino acid changes in regions predicted to span the
mitochondrial inner membrane. Among the other four TS mutants, TS20-1, TS20-29 and
LTS20-5 are low TS and HTS20-13 is high TS. All have single amino acid changes in
either TMH-2, TMH-4, or in non transmembrane domains.
Using Philius Transmembrane Prediction Software (Yeast Resource Center), a
protein structure for Pcp1p was generated on to which the corresponding mutations were
mapped (Figure 5.1).
Although in this predicted structure, the ratio of amino acids in transmembrane
domains and matrix loops is about 0.7 (139:197), the majority of amino acid changes
mapped to transmembrane spanning domains including transmembrane helix (TMH) 3, 4,
6 and the additional TMH at the N-terminus. Hydroxylamine generated random
mutations along PCP1 ORF, but the mutants with mutations in matrix loops did not
present a strong phenotype of growth difference on glucose and E/G media, unless
combined with mutation in TMH (EG20-9, G108S D309W). In other words, the amino
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acids changes in the transmembrane domains had bigger effects on the structure and
function of Pcp1p than that in the matrix loops. Recent work by DV Jeyaraju, et al,
showed that the activity of Parl requires proper positioning of S277 and H335 on TMH-4
and TMH-6. In addition, small glycine residues at the TMH-4 (G278) / TMH-6 (G338,
G342) interface were shown to be important for Parl expression and activity. For
example, the substitution of the G278 with Leu, Ala, or Arg and G342, the second G of
rhomboid conserved GxxxG motif, with Leu resulted in loss of Parl expression, while
changing the glycine at position 338 to an alanine in TMH-6 severely reduced Parl
activity [47].

Figure 5.1

Mutations mapped onto the Pcp1p predicated structure

The predicted transmembrane domains of Pcp1p are indicated by blue and yellow
highlights. Changes that resulted in a temperature sensitive phenotype are shown in
green. Amino acid changes that generated nonfunctional Pcp1p (i.e. petites) are in red.
The T962C mutation is indicated in blue. The five GxxxG motifs are underlined.
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Our results are consistent with the fact that the enzymatic activity of Pcplp also
likely requires proper packing of TMH-4 and -6. In fact, 6 out of 8 mutants identified
altered a Glycine to a larger amino acid (LTS20-5 and HTS20-13 have the same G233
amino acid change). 3 out of these 6 mutations occurred within GxxxG motifs of Pcp1p.
In accord with DV Jeyaraju’s work (G342L, loss of Parl), one of our mutants has altered
the second G of the conserved GxxxG motif (EG25-26, G320E V321A) generating a
poorly functional Pcp1p. The GxxxG motifs may be important for the structural
recognition and cleavage of rhomboid substrates, especially the highly conserved motif
that follows the catalytic Histidine residue.
The remaining mutant in putative loop structures was near the predicted
transmembrane helices (TMH-4, TMH-6), and S252N is positioned near to the catalytic
serine at position 256. Replacing Ser with the larger basic amino acid Asn and the change
of TMH structure might be the reason for the defects. The last mutation A255V is at the
end of TMH-4 and adjacent to the active site serine, which may explain loss of activities.
The nucleotide mutation T962C in PCP1 found in the original plasmid was
corrected as well as in five out of the eight mutants: pDG331 (WT PCP1), TS20-1,
TS20-29, LTS20-5, EG25-6, EG20-9.
Since HA3 tagged Pcp1p was undetectable by Western blot of total cell extract, a
HA9 tagged version of Pcp1p was generated. Although PCP1 tagged with HA9 could be
detected by Western blot, for the mutants TS20-29 and LTS20-5 the longer tag had a
negative impact on Pcp1p processing of Ccp1p. Therefore HA9 tagged Pcp1p constructs
are only useful for confirmation of Pcp1p expression.
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Pcp1p activity was determined by measuring Ccp1p and Mgm1p processing,
along with mitochondrial morphology. To date, only strains TS20-1 (PCP1 S252N,
V321A), PCP1 S252N, and PCP1 V321A were fully characterized (Table 5.1).
Table 5.1

Summary of mutations characterization

Strain and PCP1
mutation

Pcp1p level

Growth
phenotype

Mgm1p
processing

Ccp1p
processing

Mitochondrial
fragmentation

DGY388, V321A

N/A

Similar to WT

Similar to WT

76%

26.7%

DGY400, S252N

Similar to WT

Low TS

57%

60%

36.7%

DGY369, S252N,
V321A

N/A

Low TS, (more
deficient)

67%

71%

25.3%

The general mutation T962C which generated the V321A amino acid change in
TMH-6 affected Ccp1p processing more than Mgm1p processing, which suggests that the
V321A might be a substrate selective mutant. PCP1 S252N in THM-4 had more negative
effects on both Mgm1p and Ccp1p processing than PCP1 V321A. Compared to the wild
type, the mitochondria morphology of these mutants were characterized as partially
fragmented.
Hydroxylamine mutagenesis
Hydroxylamine mutagenesis generates random transition mutations (mutation
within purine or pyrimidine), and is an effective method to generate temperature sensitive
alleles in S. cerevisiae. The screen identified a small number of mutants with the TS
mutants all exhibiting poor overall growth regardless of temperature, growing slower
under all temperatures, or slight growth difference between temperatures. It might
therefore be impossible, or at least very difficult to generate a strict TS mutant.
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The structural basis of Pcp1p activity
Among the mutants identified, five out of eight contained amino acids changes in
transmembrane helices (TMH) 4 or 6, with the majority (3 out of 5) occurring in TMH 6.
Interestingly, two of the eight mutants had changed glycine at position 233 to
different amino acids, HTS20-13 (G233S) and LTS20-5 (G233D), and exhibited very
different phenotypes (Figure 4.3 d). Since this glycine localizes to a predicted nontransmembrane domain of Pcp1p, the importance of this site for Pcp1p activity needs to
be clarified in future work.
Pcp1p expression level
The HA3 tag was swapped for a HA9 in 5 mutants (TS20-1, TS20-29, LTS20-5,
EG20-9, EG25-6). TS20-29 and LTS20-5 Pcp1 level have been analyzed by western blot.
Whether there is an expression level difference for these Pcp1p mutants at different
temperatures remains to be determined.
Mgm1p and Ccp1p processing and mitochondrial morphology
Three Δpcp1 strains were generated during the course of this study, including:
MGM1-3XHA, CCP1-3XHA, and the strain with both MGM1-3XHA and CCP1-3XHA.
These are great tools to study Pcp1p activity of Mgm1p and Ccp1p processing.
To date we have only fully characterized one mutant (TS20-1SDM2 S252N) for
Mgm1p and Ccp1p processing and mitochondrial morphology at one temperature. In the
future, we need to test the other mutants and determine temperature effects. Ultimately,
this information will provide insight into the mechanism of mitochondrial rhomboids:
their important amino acids that are required for substrates recognition.
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APPENDIX A
STRAINS, PLASMIDS, PRIMERS, AND REAGENTS USED IN THIS STUDY
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Strain
DGY6
DGY11
DGY43
DGY46
DGY306
DGY321
DGY322
DGY334
DGY335
DGY336
DGY337
DGY338
DGY339
DGY340
DGY341
DGY342
DGY343
DGY344
DGY345
DGY346
DGY347
DGY348
DGY353
DGY354
DGY355
DGY356
DGY357
DGY358
DGY359
DGY360

Genotype
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103
α afg3ΔTRP1, rcal::URA3, ade2-1, his3-11,15 leu2-3,112 trp1-1, ura3-1, can1-100 (Δyta10/12)
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103 pDG (TS20-1)
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, CCP1-3XHA::Kanr
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG103
α his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG103
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG331
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG96
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103, pDG331
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103, pDG96
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG103, pDG331
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG103, pDG96
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG331
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG96
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG331
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG96
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG331
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG96
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG331
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG96
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG315
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103, pDG315
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG103, pDG315
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG315
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG315
a his3Δ1, leu2Δ0, ura3Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr, MGM1-3XHA::Kanr pDG315

Strains used in this study
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Strain
DGY361
DGY362
DGY367
DGY368
DGY369
DGY370
DGY371
DGY372
DGY373
DGY374
DGY384
DGY385
DGY386
DGY387
DGY388
DGY399
DGY400
DGY413
DGY414
DGY415
DGY416
DGY417
DGY418
DGY419
DGY420
DGY421
DGY422
DGY423
DGY424
DGY426
DGY427
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Genotype
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG331
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG96
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG337
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG337
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG315
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG295
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG338
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103, pDG295
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG103, pDG338
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG295
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG295
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG338
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG295
α his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, met15Δ0, γpcp1::LEU2, CCP1-3XHA::Kanr pDG338
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG295
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG338
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG338
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG344
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG344
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG346
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG346
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG347
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG347
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG342
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG343
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG348
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG345
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG348
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG345
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG344
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr pDG103, pDG346

Strain
DGY428
DGY429
DGY430
DGY431
DGY432
DGY433
DGY434
DGY435
DGY436
DGY437
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Genotype
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2, MGM1-3XHA::Kanr
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG354
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG356
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG357
a his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, γpcp1::LEU2 pDG103, pDG358
pDG103, pDG347
pDG103, pDG348
pDG344
pDG346
pDG347
pDG348

Description
pRS413, CEN/ARS, Ampr, HIS3
pRS416-GPDpromotor-PCP1, CEN/ARS, Ampr, URA3
pFA6a-HA3-KanMx6
pRS413 –PCP1promotor-PCP1 T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G755A T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G358A T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 C232T G925T T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G944T T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 C483T G755A:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G755A:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G698A T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G697A T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G358A:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G698A T962C:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G358A:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 C483T G755A:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G698A:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 C232T G925T:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G944T:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 T764C T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G959A T962C:HA3, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G697A T962C:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G358A:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 C232T G925T:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G944T:HA9, CEN/ARS, Amp r, HIS3
pRS413 –PCP1promotor-PCP1 G959A T962C:HA9, CEN/ARS, Amp r, HIS3

Plasmids used in this study

Plasmid Name
pDG96
pDG103
pDG266
pDG295
pDG315
pDG318
pDG326
pDG329
pDG331
pDG337
pDG338
pDG342
pDG343
pDG344
pDG345
pDG346
pDG347
pDG348
pDG349
pDG350
pDG351
pDG352
pDG353
pDG354
pDG355
pDG356
pDG357
pDG358
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MGM1 tagging R1
MGM1 tagging detection
Sense
PCP1 ORF: 610-631, Sense
PCP1 ORF: 699-678, Antisense
PCP1 ORF: 1005-1029, Sense
PCP1 ORF: 1130-1110, Antisense
PCP1 ORF: 1740-1720, Antisense
PCP1 ORF sense
PCP1 ORF antisense
CCP1, F1 tagging
CCP1,R1 tagging
CCP1 integration check primer

DG101

DG179
DG180
DG181
DG182
DG183
DG184
DG185
DG186
DG187
DG188

DG108

5’GTTCCTGGTTTGAGATCGACG3’
5’CTCTTCCGAGGAATTTGCCGACAAAGGC3’
5’GGTGTAAGCTCTGTTATGCTCGG3’
5’GAGTATCGACGTGCTCTGGG3’
5’GGCTAGGCGTGCCAGTTTTGG3’
5’GGTGGCTCTATGGGGGTCTTGTACGGAGG3’
5’CCATCCGTACAAGACCCCCATCATAGAGCCACC3’
5’AAGACGCGCCCAGTCCATTTATTTTCAAGACTTTAGAGGAACAAGGTTTACGGATCCCCGGGTTAATTAA3’
5’ATGATATTCAGAAAAAAGCATAAGCCTAAATAATAATAAAGAATTCGAGCTCGTTTAAAC3’
5’AGGATCCCAAGTACTTAA3’

5’AAACCACCTACCAGCAGCCTG3’
5’GAGAAAATAGATTCAATCTTGGTTTTCAAGAAAAGCTACAAGGGCGTCTCCAAAAATTTACGGATCCCCGGGT
TAATTAA3’
5’TATAACGGTAAAAAATGCTATTTACAAATTCTCTAATGACACTGAATTCGTCGTTTAAAC3’
test,5’GCTAAGGAAGATCCGAAGATTTC3’

MGM1 tagging F2

DG86

DG18

DG100

Sequence
5’GGCACTTAGGTATGAACATGCTAGCGTTGTGG3’
test,5’GCTCGCAGGTCTGCAGCGAGGAGCCG3’

Description
PCP1 ORF, Sense
Kanamycin
detection
Antisense
PCP1 ORF, Antisense

Primers used in this study

Primer
DG11
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Description
2% Peptone, 1% Yeast Extract, 2% Bacto Agar, 2% glucose
0.72% Yeast Nitrogen Base with 16 amino acids and Adenine, w/o Uracil, 2% glucose
0.72% Yeast Nitrogen Base with 15 amino acids and Adenine w/o Uracil and His, 2% glucose
0.72% Yeast Nitrogen Base with optional amino acids, Adenine and Uracil, 0.1%5-FOA, 2% glucose
2% Peptone, 1% Yeast Extract, 2% Bacto Agar, 2% glucose, 0.2g/L Kanamycin
Super Optimal Broth, 2%Tryptone, 0.5%Yeast Extract, 8.5mM NaCl, 2.5mM KCl, 10mM MgCl2 20mM glucose,
SOC
pH7.0-7.5
LB
1% Tryptone, 0.5% Yeast Extract, 1% Sodium Chloride, 15% Bacto Agar
LB Amp
1% Tryptone, 0.5% Yeast Extract, 1% Sodium Chloride, 15% Bacto Agar, 100μg/ml Ampicilin
-Leu, -Met, -Lys
0.72% Yeast Nitrogen Base with 13 amino acids, Adenine and uracil w/o uracil, Leu, Met and Lys, 2% glucose
-Leu
0.72% Yeast Nitrogen Base with 15 amino acids uracil and Adenine, w/o Leu, 2% glucose
-Met
0.72% Yeast Nitrogen Base with 15 amino acids uracil and Adenine, w/o Met, 2% glucose
-Lys
0.72% Yeast Nitrogen Base with 15 amino acids uracil and Adenine, w/o Lys, 2% glucose
SDmin
Yeast nitrogen base (-AA), 2% glucose, 2% agar
M9
0.6% Na2HPO47H2O, 0.3%KH2PO4, 0.05% NaCl, 0.1% NH4Cl, 2mM MgSO4, 0.1mM CaCl2, 2% glucose, pH7.4
Speroplast buffer
1M Sorbitol, 20mM Tris pH 7.5, 10mM EDTA pH 8.0; 0.15μg/μl 100T Zymolyase, and 0.2% β mercapto-ethanol
Qiagen P1 buffer
50 mM Tris-Cl, pH8.0, 10mM EDTA, 100μg/ml RNase A
Qiagen P2 buffer
200mM NaOH, 1% SDS w/v
2.5XTBE
200mM Tris base, 200mM Boric Acid, 5mM EDTA pH8.0, dilute to 0.5X TBE to use
5XDNA loading buffer
0.25% Bromophenol bule, 0.25% Xylene Cyanol FF, 15% Ficoll, 1mM EDTA, 0.01%SDS
10XTBS
1M Tris, 1.5M NaCl, pH7.4
Amido Black stain
0.1% Amido Black, 45% Methanol, 10% acetic acid
SDS loading buffer
20μl 0.5M Tris base, 6.25% SDS; 12μl 50% Glycerol, 0.02% Bromophenol Blue; 3μl 1M DTT
5XSDS running buffer
0.25M Tris Base, 2M Glycine, 20mM SDS, stir overnight
Western blot transfer buffer
240ml 5XSDS running buffer, 600ml 100% Methanol, bring up volume to 3L with dH2O, prechill overnight at 4℃
Vertical sealing gel stock
10% acrylamide, 161μl of 100% TEMED per 100ml solution
solution
10% AMPS
0.3g Ammonium Persulfate, 3ml of dH2O, store at 4℃
Membrane stripping buffer
2% SDS, 62.5mM Tris, pH6.8, 100mM β-ME

Media and Reagents in this study

Media or Reagent
YPD
-Ura
-Ura, -His
5-FOA
YPD G418
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Media or Reagent
Cell lysis buffer
Hydroxylamine
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Description
40mM Tris base, 0.5mM EDTA pH8, 0.05% SDS, 14mM β-ME
1M hydroxylamine hydrochloride, 0.45μM NaOH

